These results demonstrated that ADAM17 knockdown in combination with eplerenone treatment can further improve the systolic and diastolic dysfunction of mice with DCM without affecting blood pressure and disturbing blood potassium levels. The gene discussed is ADAM17; the disease is familial dilated cardiomyopathy.